TY - JOUR AU - Tunn, U. PY - 2007 DA - 2007// TI - The current status of intermittent androgen deprivation (IAD) therapy for prostate cancer: putting IAD under the spotlight JO - BJU Int VL - 99 UR - https://doi.org/10.1111/j.1464-410X.2007.06596.x DO - 10.1111/j.1464-410X.2007.06596.x ID - Tunn2007 ER - TY - STD TI - National Cancer Institute: Prostate Cancer Treatment (PDQ®). General Information About Prostate Cancer. http://www.cancer.gov/cancertopics/pdq/treatment/prostate. Accessed on 16 December 2013 UR - http://www.cancer.gov/cancertopics/pdq/treatment/prostate ID - ref2 ER - TY - JOUR AU - Choong, K. AU - Basaria, S. PY - 2010 DA - 2010// TI - Emerging cardiometabolic complications of androgen deprivation therapy JO - Aging Male VL - 13 UR - https://doi.org/10.3109/13685530903410625 DO - 10.3109/13685530903410625 ID - Choong2010 ER - TY - JOUR AU - Harle, L. K. AU - Maggio, M. AU - Shahani, S. AU - Braga-Basaria, M. AU - Basaria, S. PY - 2006 DA - 2006// TI - Endocrine complications of androgen-deprivation therapy in men with prostate cancer JO - Clin Adv Hematol Oncol VL - 4 ID - Harle2006 ER - TY - JOUR AU - Abrahamsson, P. A. PY - 2010 DA - 2010// TI - Potential benefits of intermittent androgen suppression therapy in the treatment of prostate cancer: a systematic review of the literature JO - Eur Urol VL - 57 UR - https://doi.org/10.1016/j.eururo.2009.07.049 DO - 10.1016/j.eururo.2009.07.049 ID - Abrahamsson2010 ER - TY - JOUR AU - Shaw, G. L. AU - Wilson, P. AU - Cuzick, J. AU - Prowse, D. M. AU - Goldenberg, S. L. AU - Spry, N. A. PY - 2007 DA - 2007// TI - International study into the use of intermittent hormone therapy in the treatment of carcinoma of the prostate: a meta-analysis of 1446 patients JO - BJU Int VL - 99 UR - https://doi.org/10.1111/j.1464-410X.2007.06770.x DO - 10.1111/j.1464-410X.2007.06770.x ID - Shaw2007 ER - TY - STD TI - National Institute for Health and Clinical Excellence: Prostate cancer: diagnosis and treatment. February 2008. http://publications.nice.org.uk/prostate-cancer-cg58/guidance#metastatic-prostate-cancer. Accessed on 16 December 2013 UR - http://publications.nice.org.uk/prostate-cancer-cg58/guidance#metastatic-prostate-cancer ID - ref7 ER - TY - JOUR AU - Hussain, M. AU - Tangen, C. M. AU - Berry, D. L. AU - Higano, C. S. AU - Crawford, E. D. AU - Liu, G. PY - 2013 DA - 2013// TI - Intermittent versus continuous androgen deprivation in prostate cancer JO - N Engl J Med VL - 368 UR - https://doi.org/10.1056/NEJMoa1212299 DO - 10.1056/NEJMoa1212299 ID - Hussain2013 ER - TY - JOUR AU - Crook, J. M. AU - O’Callaghan, C. J. AU - Duncan, G. AU - Dearnaley, D. P. AU - Higano, C. S. AU - Horwitz, E. M. PY - 2012 DA - 2012// TI - Intermittent androgen suppression for rising PSA level after radiotherapy JO - N Engl J Med VL - 367 UR - https://doi.org/10.1056/NEJMoa1201546 DO - 10.1056/NEJMoa1201546 ID - Crook2012 ER - TY - JOUR AU - Klotz, L. AU - O’ Callaghan, C. J. AU - Ding, K. AU - Dearnaley, D. P. AU - Higano, C. S. AU - Horwitz, E. M. PY - 2011 DA - 2011// TI - A phase III randomized trial comparing intermittent versus continuous androgen suppression for patients with PSA progression after radical therapy: NCIC CTG PR.7/SWOG JPR.7/CTSU JPR.7/UK Intercontinental Trial CRUKE/01/013 JO - J Clin Oncol VL - 2011 ID - Klotz2011 ER - TY - JOUR AU - Salonen, A. J. AU - Taari, K. AU - Ala-Opas, M. AU - Viitanen, J. AU - Lundstedt, S. AU - Tammela, T. L. PY - 2012 DA - 2012// TI - The FinnProstate Study VII: intermittent versus continuous androgen deprivation in patients with advanced prostate cancer JO - J Urol VL - 187 UR - https://doi.org/10.1016/j.juro.2012.01.122 DO - 10.1016/j.juro.2012.01.122 ID - Salonen2012 ER - TY - JOUR AU - Salonen, A. J. AU - Taari, K. AU - Ala-Opas, M. AU - Viitanen, J. AU - Lundstedt, S. AU - Tammela, T. L. PY - 2013 DA - 2013// TI - Advanced prostate cancer treated with intermittent or continuous androgen deprivation in the randomised FinnProstate Study VII: quality of life and adverse effects JO - Eur Urol VL - 63 UR - https://doi.org/10.1016/j.eururo.2012.07.040 DO - 10.1016/j.eururo.2012.07.040 ID - Salonen2013 ER - TY - JOUR AU - Dickersin, K. AU - Scherer, R. AU - Lefebvre, C. PY - 1994 DA - 1994// TI - Identifying relevant studies for systematic reviews JO - BMJ VL - 309 UR - https://doi.org/10.1136/bmj.309.6964.1286 DO - 10.1136/bmj.309.6964.1286 ID - Dickersin1994 ER - TY - CHAP AU - Higgins, J. P. T. AU - Green, S. PY - 2006 DA - 2006// TI - Cochrane Handbook for Systematic Reviews of Interventions 4.2.6 [updated September 2006] BT - The Cochrane Library, Issue 4, 2006 PB - Sons, Ltd CY - Chichester, UK ID - Higgins2006 ER - TY - JOUR AU - Castro, A. A. AU - Clark, O. A. AU - Atallah, A. N. PY - 1999 DA - 1999// TI - Optimal search strategy for clinical trials in the Latin American and Caribbean Health Science Literature database (LILACS database): update JO - Sao Paulo Med J VL - 117 UR - https://doi.org/10.1590/S1516-31801999000300011 DO - 10.1590/S1516-31801999000300011 ID - Castro1999 ER - TY - BOOK AU - Egger, M. AU - Smith, G. D. AU - Altman, D. PY - 2001 DA - 2001// TI - Systematic Reviews in Health Care PB - BMJ Books CY - London UR - https://doi.org/10.1002/9780470693926 DO - 10.1002/9780470693926 ID - Egger2001 ER - TY - BOOK PY - 2011 DA - 2011// TI - [Computer program]. Version 5.1 PB - The Nordic Cochrane Centre, The Cochrane Collaboration CY - Copenhagen ID - ref17 ER - TY - JOUR AU - Parmar, M. K. AU - Torri, V. AU - Stewart, L. PY - 1998 DA - 1998// TI - Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints JO - Stat Med VL - 17 UR - https://doi.org/3.0.CO;2-8 DO - 3.0.CO;2-8 ID - Parmar1998 ER - TY - JOUR AU - Higgins, J. P. AU - Thompson, S. G. AU - Deeks, J. J. AU - Altman, D. G. PY - 2003 DA - 2003// TI - Measuring inconsistency in meta-analyses JO - BMJ VL - 327 UR - https://doi.org/10.1136/bmj.327.7414.557 DO - 10.1136/bmj.327.7414.557 ID - Higgins2003 ER - TY - JOUR AU - Yang, K. AU - Wang, Y. J. AU - Chen, X. R. AU - Chen, H. N. PY - 2010 DA - 2010// TI - Effectiveness and safety of bevacizumab for unresectable non-small-cell lung cancer: a meta-analysis JO - Clin Drug Investig VL - 30 UR - https://doi.org/10.2165/11532260-000000000-00000 DO - 10.2165/11532260-000000000-00000 ID - Yang2010 ER - TY - CHAP AU - Deeks, J. J. H. J. AU - Altman, D. G. ED - Higgins, J. P. ED - Green, S. PY - 2006 DA - 2006// TI - Analysing and presenting results BT - Cochrane Handbook for Systematic Reviews of In- terventions (ed 4.2.6 [updated September 2006]) PB - Sons, Ltd CY - Chichester, United Kingdom ID - Deeks2006 ER - TY - JOUR AU - DerSimonian, R. AU - Laird, N. PY - 1986 DA - 1986// TI - Meta-analysis in clinical trials JO - Control Clin Trials VL - 7 UR - https://doi.org/10.1016/0197-2456(86)90046-2 DO - 10.1016/0197-2456(86)90046-2 ID - DerSimonian1986 ER - TY - JOUR AU - Egger, M. AU - Davey Smith, G. AU - Schneider, M. AU - Minder, C. PY - 1997 DA - 1997// TI - Bias in meta-analysis detected by a simple, graphical test JO - BMJ VL - 315 UR - https://doi.org/10.1136/bmj.315.7109.629 DO - 10.1136/bmj.315.7109.629 ID - Egger1997 ER - TY - JOUR AU - McQuay, H. J. AU - Moore, R. A. PY - 1997 DA - 1997// TI - Using numerical results from systematic reviews in clinical practice JO - Ann Intern Med VL - 126 UR - https://doi.org/10.7326/0003-4819-126-9-199705010-00007 DO - 10.7326/0003-4819-126-9-199705010-00007 ID - McQuay1997 ER - TY - JOUR AU - Smeeth, L. AU - Haines, A. AU - Ebrahim, S. PY - 1999 DA - 1999// TI - Numbers needed to treat derived from meta-analyses–sometimes informative, usually misleading JO - BMJ VL - 318 UR - https://doi.org/10.1136/bmj.318.7197.1548 DO - 10.1136/bmj.318.7197.1548 ID - Smeeth1999 ER - TY - JOUR AU - Altman, D. G. AU - Deeks, J. J. PY - 2002 DA - 2002// TI - Meta-analysis, Simpson’s paradox, and the number needed to treat JO - BMC Med Res Methodol VL - 2 UR - https://doi.org/10.1186/1471-2288-2-3 DO - 10.1186/1471-2288-2-3 ID - Altman2002 ER - TY - JOUR AU - Liberati, A. AU - Altman, D. G. AU - Tetzlaff, J. AU - Mulrow, C. AU - Gotzsche, P. C. AU - Ioannidis, J. P. PY - 2009 DA - 2009// TI - The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration JO - Ann Intern Med VL - 151 UR - https://doi.org/10.7326/0003-4819-151-4-200908180-00136 DO - 10.7326/0003-4819-151-4-200908180-00136 ID - Liberati2009 ER - TY - JOUR AU - Klotz, L. H. AU - Herr, H. W. AU - Morse, M. J. AU - Whitmore, W. F. PY - 1986 DA - 1986// TI - Intermittent endocrine therapy for advanced prostate cancer JO - Cancer VL - 58 UR - https://doi.org/3.0.CO;2-N DO - 3.0.CO;2-N ID - Klotz1986 ER - TY - JOUR AU - Goldenberg, S. L. AU - Bruchovsky, N. AU - Gleave, M. E. AU - Sullivan, L. D. AU - Akakura, K. PY - 1995 DA - 1995// TI - Intermittent androgen suppression in the treatment of prostate cancer: a preliminary report JO - Urology VL - 45 UR - https://doi.org/10.1016/S0090-4295(99)80092-2 DO - 10.1016/S0090-4295(99)80092-2 ID - Goldenberg1995 ER - TY - JOUR AU - Higano, C. S. AU - Ellis, W. AU - Russell, K. AU - Lange, P. H. PY - 1996 DA - 1996// TI - Intermittent androgen suppression with leuprolide and flutamide for prostate cancer: a pilot study JO - Urology VL - 48 UR - https://doi.org/10.1016/S0090-4295(96)00381-0 DO - 10.1016/S0090-4295(96)00381-0 ID - Higano1996 ER - TY - JOUR AU - Oliver, R. T. AU - Williams, G. AU - Paris, A. M. AU - Blandy, J. P. PY - 1997 DA - 1997// TI - Intermittent androgen deprivation after PSA-complete response as a strategy to reduce induction of hormone-resistant prostate cancer JO - Urology VL - 49 UR - https://doi.org/10.1016/S0090-4295(96)00373-1 DO - 10.1016/S0090-4295(96)00373-1 ID - Oliver1997 ER - TY - JOUR AU - Bierkens, A. F. AU - Hendrikx, A. J. AU - De La Rosette, J. J. AU - Stultiens, G. N. AU - Beerlage, H. P. AU - Arends, A. J. PY - 1998 DA - 1998// TI - Treatment of mid- and lower ureteric calculi: extracorporeal shock-wave lithotripsy vs laser ureteroscopy. A comparison of costs, morbidity and effectiveness JO - Br J Urol VL - 81 UR - https://doi.org/10.1046/j.1464-410x.1998.00510.x DO - 10.1046/j.1464-410x.1998.00510.x ID - Bierkens1998 ER - TY - JOUR AU - Grossfeld, G. D. AU - Small, E. J. AU - Carroll, P. R. PY - 1998 DA - 1998// TI - Intermittent androgen deprivation for clinically localized prostate cancer: initial experience JO - Urology VL - 51 UR - https://doi.org/10.1016/S0090-4295(97)00488-3 DO - 10.1016/S0090-4295(97)00488-3 ID - Grossfeld1998 ER - TY - STD TI - da Silva Jr F C, Calais Da Silva F, Brausi M, Goncalves F, Kliment J, Queimadelos A: Pooled Analysis of two protocols of intermittent hormonal therapy in advanced prostatic cancer. : AUA 2013 Annual Meeting, 777- ID - ref34 ER - TY - BOOK AU - De Conti, P. AU - Atallah Alvaro, N. AU - Arruda Homero, O. AU - Soares Bernardo, G. O. AU - El Dib Regina, P. AU - Wilt Timothy, J. PY - 2007 DA - 2007// TI - Intermittent versus continuous androgen suppression for prostatic cancer UR - https://doi.org/10.1002/14651858.CD005009.pub2 DO - 10.1002/14651858.CD005009.pub2 ID - De Conti2007 ER - TY - JOUR AU - Loblaw, D. A. AU - Virgo, K. S. AU - Nam, R. AU - Somerfield, M. R. AU - Ben-Josef, E. AU - Mendelson, D. S. PY - 2007 DA - 2007// TI - Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 update of an American Society of Clinical Oncology practice guideline JO - J Clin Oncol VL - 25 UR - https://doi.org/10.1200/JCO.2006.10.1949 DO - 10.1200/JCO.2006.10.1949 ID - Loblaw2007 ER - TY - JOUR AU - Heidenreich, A. AU - Aus, G. AU - Bolla, M. AU - Joniau, S. AU - Matveev, V. B. AU - Schmid, H. P. PY - 2008 DA - 2008// TI - EAU guidelines on prostate cancer JO - Eur Urol VL - 53 UR - https://doi.org/10.1016/j.eururo.2007.09.002 DO - 10.1016/j.eururo.2007.09.002 ID - Heidenreich2008 ER - TY - JOUR AU - Heidenreich, A. AU - Pfister, D. AU - Ohlmann, C. H. AU - Engelmann, U. H. PY - 2008 DA - 2008// TI - Androgen deprivation for advanced prostate cancer JO - Urologe A VL - 47 UR - https://doi.org/10.1007/s00120-008-1636-2 DO - 10.1007/s00120-008-1636-2 ID - Heidenreich2008 ER - TY - JOUR AU - Heidenreich, A. AU - Aus, G. AU - Bolla, M. AU - Joniau, S. AU - Matveev, V. B. AU - Schmid, H. P. PY - 2009 DA - 2009// TI - EAU guidelines on prostate cancer JO - Actas Urol Esp VL - 33 UR - https://doi.org/10.1016/S0210-4806(09)74110-5 DO - 10.1016/S0210-4806(09)74110-5 ID - Heidenreich2009 ER - TY - JOUR AU - Buchan, N. C. AU - Goldenberg, S. L. PY - 2010 DA - 2010// TI - Intermittent versus continuous androgen suppression therapy: do we have consensus yet? JO - Curr Oncol VL - 17 ID - Buchan2010 ER - TY - JOUR AU - Keizman, D. AU - Carducci, M. A. PY - 2009 DA - 2009// TI - Intermittent androgen deprivation–questions remain JO - Nat Rev Urol VL - 6 UR - https://doi.org/10.1038/nrurol.2009.145 DO - 10.1038/nrurol.2009.145 ID - Keizman2009 ER - TY - JOUR AU - Gruca, D. AU - Bacher, P. AU - Tunn, U. PY - 2012 DA - 2012// TI - Safety and tolerability of intermittent androgen deprivation therapy: a literature review JO - Int J Urol VL - 19 UR - https://doi.org/10.1111/j.1442-2042.2012.03001.x DO - 10.1111/j.1442-2042.2012.03001.x ID - Gruca2012 ER - TY - JOUR AU - Organ, M. AU - Wood, L. AU - Wilke, D. AU - Skedgel, C. AU - Cheng, T. AU - North, S. PY - 2013 DA - 2013// TI - Intermittent LHRH therapy in the management of castrate-resistant prostate cancer (CRPCa): results of a multi-institutional randomized prospective clinical trial JO - Am J Clin Oncol VL - 36 UR - https://doi.org/10.1097/COC.0b013e31825d5664 DO - 10.1097/COC.0b013e31825d5664 ID - Organ2013 ER - TY - JOUR AU - da Silva FE, C. AU - Bono, A. V. AU - Whelan, P. AU - Brausi, M. AU - Marques Queimadelos, A. AU - Martin, J. A. PY - 2009 DA - 2009// TI - Intermittent androgen deprivation for locally advanced and metastatic prostate cancer: results from a randomised phase 3 study of the South European Uroncological Group JO - Eur Urol VL - 55 UR - https://doi.org/10.1016/j.eururo.2009.02.016 DO - 10.1016/j.eururo.2009.02.016 ID - da Silva FE2009 ER - TY - JOUR AU - da Silva FM, C. AU - da SIlva F, C. AU - Bono, A. AU - Whelan, P. AU - Brausi, M. AU - Queimadelos, A. PY - 2011 DA - 2011// TI - Phase III study of intermittent MAB vs continuos MAB JO - J Urol VL - 185 UR - https://doi.org/10.1016/j.juro.2011.02.1684 DO - 10.1016/j.juro.2011.02.1684 ID - da Silva FM2011 ER - TY - JOUR AU - Tunn, U. AU - Kurek, R. AU - Keinle, E. PY - 2004 DA - 2004// TI - Intermittent is as effective as continuous androgen deprivation in patients with PSA relapse after radical prostatectomy JO - J Urol VL - 171 UR - https://doi.org/10.1097/01.ju.0000102933.25905.08 DO - 10.1097/01.ju.0000102933.25905.08 ID - Tunn2004 ER - TY - JOUR AU - Tunn, U. W. AU - Canepa, G. AU - Kochanowsky, A. AU - Kienle, E. PY - 2012 DA - 2012// TI - Testosterone recovery in the off-treatment time in prostate cancer patients undergoing intermittent androgen deprivation therapy JO - Prostate Cancer Prostatic Dis VL - 15 UR - https://doi.org/10.1038/pcan.2012.12 DO - 10.1038/pcan.2012.12 ID - Tunn2012 ER - TY - BOOK AU - Verhagen, P. C. M. S. AU - Wissenburg, L. D. AU - Wildhagen, M. F. PY - 2008 DA - 2008// TI - Quality of life effects of intermittent and continuous hormonal therapy by cyproterone acetate (CPA) for metastatic prostate cancer [abstract 541] PB - Presented at: 23rd Annual Congress of the European Association of Urology; March 26–29, 2008 CY - Milan, Italy ID - Verhagen2008 ER - TY - JOUR AU - Verhagen, P. C. M. S. AU - Wildhagen, M. F. AU - Verkerk, A. AU - Bolle, W. A. B. M. PY - 2013 DA - 2013// TI - Intermittent versus continuous cyproterone acetate in bone metastatic prostate cancer: Results of a randomized trial JO - Eur Urol VL - 12 UR - https://doi.org/10.1016/S1569-9056(13)61162-8 DO - 10.1016/S1569-9056(13)61162-8 ID - Verhagen2013 ER - TY - JOUR AU - Mottet, N. AU - Van Damme, J. AU - Loulidi, S. AU - Russel, C. AU - Leitenberger, A. AU - Wolff, J. M. PY - 2012 DA - 2012// TI - Intermittent hormonal therapy in the treatment of metastatic prostate cancer: a randomized trial JO - BJU Int VL - 110 UR - https://doi.org/10.1111/j.1464-410X.2012.11120.x DO - 10.1111/j.1464-410X.2012.11120.x ID - Mottet2012 ER - TY - JOUR AU - de Leval, J. AU - Boca, P. AU - Yousef, E. AU - Nicolas, H. AU - Jeukenne, M. AU - Seidel, L. PY - 2002 DA - 2002// TI - Intermittent versus continuous total androgen blockade in the treatment of patients with advanced hormone-naive prostate cancer: results of a prospective randomized multicenter trial JO - Clin Prostate Cancer VL - 1 UR - https://doi.org/10.3816/CGC.2002.n.018 DO - 10.3816/CGC.2002.n.018 ID - de Leval2002 ER - TY - CHAP AU - Langenhuijsen, J. F. AU - Badhauser, D. AU - Schaaf, B. AU - Kiemeney, L. A. AU - Witjes, J. A. AU - Mulders, P. F. PY - 2011 DA - 2011// TI - Continuous vs. intermittent androgen deprivation therapy for metastatic prostate cancer BT - Urol Oncol ID - Langenhuijsen2011 ER - TY - BOOK AU - Langenhuijsen, J. F. AU - Schasfoort, E. M. C. AU - Heathcote, P. PY - 2008 DA - 2008// TI - Intermittent androgen suppression in patients with advanced prostate cancer: an update of the TULP survival data [abstract 538] PB - Presented at: 23rd Annual Congress of the European Association of Urology; March 26–29, 2008 CY - Milan, Italy ID - Langenhuijsen2008 ER - TY - JOUR AU - Hering, F. AU - Rodrigues, P. R. T. AU - Lipay, M. A. AU - Nesrallah, L. AU - Srougi, M. PY - 2000 DA - 2000// TI - Metastatic adenocarcinoma of the prostate: comparison between continuous and intermittent hormonal treatment JO - Braz J Urol VL - 26 ID - Hering2000 ER - TY - JOUR AU - Hussain, M. AU - Tangen, C. M. AU - Higano, C. AU - Schelhammer, P. F. AU - Faulkner, J. AU - Crawford, E. D. PY - 2006 DA - 2006// TI - Absolute prostate-specific antigen value after androgen deprivation is a strong independent predictor of survival in new metastatic prostate cancer: data from Southwest Oncology Group Trial 9346 (INT-0162) JO - J Clin Oncol VL - 24 UR - https://doi.org/10.1200/JCO.2006.06.4246 DO - 10.1200/JCO.2006.06.4246 ID - Hussain2006 ER - TY - BOOK AU - Miller, K. AU - Steiner, U. AU - Lingnau, A. PY - 2007 DA - 2007// TI - Randomised prospective study of intermittent versus continuous androgen suppression in advanced prostate cancer [abstract 5105] PB - Presented at: American Society of Clinical Oncology; June 1–5 CY - Chicago, IL, USA ID - Miller2007 ER - TY - JOUR AU - Irani, J. AU - Celhay, O. AU - Hubert, J. AU - Bladou, F. AU - Ragni, E. AU - Trape, G. PY - 2008 DA - 2008// TI - Continuous versus six months a year maximal androgen blockade in the management of prostate cancer: a randomised study JO - Eur Urol VL - 54 UR - https://doi.org/10.1016/j.eururo.2008.02.024 DO - 10.1016/j.eururo.2008.02.024 ID - Irani2008 ER - TY - CHAP AU - Silva, F. C. AU - Silva, F. M. AU - Goncalves, F. AU - Santos, A. AU - Kliment, J. AU - Whelan, P. PY - 2013 DA - 2013// TI - Locally advanced and metastatic prostate cancer treated with intermittent androgen monotherapy or maximal androgen blockade: results from a randomised phase 3 study by the south European uroncological group BT - Eur Urol ID - Silva2013 ER - TY - BOOK PY - 2007 DA - 2007// TI - Guideline for the management of clinically localized prostate cancer ID - ref59 ER - TY - STD TI - Heidenreich A, Bastian PJ, Bellmunt J: Guidelines on prostate cancer. Eur Association Urol. Web site http://wwwuroweborg/gls/pdf/08ProstateCancer_LRMarch13th2012pdf UR - http://www.uroweborg/gls/pdf/08ProstateCancer_LRMarch13th2012pdf ID - ref60 ER - TY - JOUR AU - Sciarra, A. AU - Abrahamsson, P. A. AU - Brausi, M. AU - Galsky, M. AU - Mottet, N. AU - Sartor, O. PY - 2013 DA - 2013// TI - Intermittent androgen-deprivation therapy in prostate cancer: a critical review focused on phase 3 trials JO - Eur Urol VL - 64 UR - https://doi.org/10.1016/j.eururo.2013.04.020 DO - 10.1016/j.eururo.2013.04.020 ID - Sciarra2013 ER - TY - JOUR AU - Niraula, S. AU - Le, L. W. AU - Tannock, I. F. PY - 2013 DA - 2013// TI - Treatment of prostate cancer with intermittent versus continuous androgen deprivation: a systematic review of randomized trials JO - J Clin Oncol VL - 31 UR - https://doi.org/10.1200/JCO.2012.46.5492 DO - 10.1200/JCO.2012.46.5492 ID - Niraula2013 ER - TY - JOUR AU - Tsai, H. T. AU - Penson, D. F. AU - Makambi, K. H. AU - Lynch, J. H. AU - Van Den Eeden, S. K. AU - Potosky, A. L. PY - 2013 DA - 2013// TI - Efficacy of intermittent androgen deprivation therapy vs conventional continuous androgen deprivation therapy for advanced prostate cancer: a meta-analysis JO - Urology VL - 82 UR - https://doi.org/10.1016/j.urology.2013.01.078 DO - 10.1016/j.urology.2013.01.078 ID - Tsai2013 ER - TY - JOUR AU - De Laurentiis, M. AU - Cancello, G. AU - D’Agostino, D. AU - Giuliano, M. AU - Giordano, A. AU - Montagna, E. PY - 2008 DA - 2008// TI - Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials JO - J Clin Oncol VL - 26 UR - https://doi.org/10.1200/JCO.2007.11.3787 DO - 10.1200/JCO.2007.11.3787 ID - De Laurentiis2008 ER - TY - CHAP AU - Jespersen, C. G. AU - Norgaard, M. AU - Borre, M. PY - 2013 DA - 2013// TI - Androgen-deprivation therapy in treatment of prostate cancer and risk of myocardial infarction and stroke: a nationwide Danish population-based cohort study BT - Eur Urol ID - Jespersen2013 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2490/14/9/prepub UR - http://www.biomedcentral.com/1471-2490/14/9/prepub ID - ref66 ER -